recent articles
From Proscia: Siemens Healthineers expands its Enterprise Imaging offering with Proscia’s Concentriq Dx platform for digital pathology PHILADELPHIA – March 16, 2022 - Proscia®, the leader in digital and computational pathology...
Multi-year agreement will power 100% digitization of Uppsala’s clinical workflow and future AI integrations UPPSALA, Sweden & PHILADELPHIA, PA - February 3, 2022 - Proscia®, the leader in digital and computational...
Join Proscia, pathology leaders, and healthcare innovators to experience this vital event for diagnostic laboratories: Future Ready Pathology. As pathology labs modernize to adapt to mounting pressures in the post-pandemic era, learn how...
An event for the modern diagnostic lab. Join Proscia, pathology leaders, and healthcare innovators for a can’t-miss event for diagnostic laboratories: Future Ready Pathology. June 15, 2021 | 11AM - 12:15PM ET As pathology labs...
Collaboration brings computational pathology to one of Europe’s largest laboratory networks PHILADELPHIA & STOCKHOLM--(BUSINESS WIRE)--Proscia®, a leading provider of digital and computational pathology solutions, and Unilabs, a...
Proscia Offers Concentriq Dx for Remote Use in Clinical Practice Du...
- Advocacy
- Anatomic Pathology
- Artificial Intelligence
- Clinical Laboratories
- Cloud Computing
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- Government
- Health Technology Collaboration
- Image Analysis
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Management & Operations
- Pathology News
- TeleHealth
- Vendor products
- Web/Tech
- Whole slide
The FDA has issued guidance aimed at expanding the use of remote digital pathology devices during the COVID-19 pandemic. In response to the FDA’s guidance, Proscia announced today that we are now offering our Concentriq Dx digital...